AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients

Recruitingn/aAges 18 Years - anyAllPatenSee Ltd.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a prospective, non-interventional, single arm, international multicenter study in which up to 120 adult participants with kidney failure requiring regular hemodialysis through arteriovenous (AV) access (AV fistula or graft) will be recruited and evaluated using the PatenSee system. Data captured on the PatenSee system will be analyzed and evaluated against standard of care clinical monitoring of AV accesses.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Male and female adult patient aged โ‰ฅ18 years old 2. Patient has a non-reversible kidney failure that requires long-term hemodialysis 3. Patient has a functioning AV access (AVF/G) in the upper extremity 4. Patient is able and willing to provide consent by signing an EC/IRB approved informed consent form 5. Patient is willing and able to follow the requirements of the study Exclusion Criteria: 1. An active AV access infection 2. An AV access condition that will likely require revision, e.g., symptomatic steal syndrome 3. Expected to recover kidney function, receive a kidney transplant, transfer to peritoneal dialysis (PD) or transfer to non-study site during the study period. 4. Any reason per investigator's discretion for which the patient is not suitable for the study 5. Any medical or psychiatric illness, which in the opinion of the investigator would compromise the patient's ability to adhere to study requirements 6. Previous participation in an interventional study within 30 days prior to study enrollment that may interfere with evaluation of the study endpoints 7. Female patient is pregnant or breastfeeding
๐Ÿ’Š

What it tests

  • PatenSee System
๐Ÿ“

Where

2 sites
Henry Ford Hospital
Detroit, United States
Meir Medical Center
Kfar Saba, Israel
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy